Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML Study IVSusanne Saußele, Martin C. Müller, Benjamin Hanfstein et al.|Blood|2015Cited by 200
Suppressed neutrophil function as a risk factor for severe infection after cytotoxic chemotherapy in patients with acute nonlymphocytic leukemiaKai Hübel, Andreas Engert, K. Hegener et al.|Annals of Hematology|1999Cited by 55
Phase I study of BBR 2778, a new aza-anthracenedione, in advanced or refractory non-Hodgkin’s lymphomaPeter Borchmann, Andreas Engert, R. Schnell et al.|Annals of Oncology|2001Cited by 52